Good question and worth looking into
From Ymani’s post:
FDA Approves First Oral Blood Thinning Medication for Children
For Immediate Release:
June 21, 2021
“Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days. The FDA also approved Pradaxa oral pellets to prevent recurrent clots among patients 3 months to less than 12 years old who completed treatment for their first venous thromboembolism.”
Pinging out research request; when did this drug begin its clinical trials?
Also, see thread BTT about efficacy and effects of the covid shots:
https://freerepublic.com/focus/f-news/3988931/posts